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Abstract 
The rate of liposome clearance from blood by the reticuloendothelial system (RES), primarily the Kupffer cells of the liver, depends 
largely on liposome composition. Inclusion of phosphatidylserine or dicetyl phosphate into liposomes with a simple composition of 
phosphatidylcholine and cholesterol increases liposome clearance, while inclusion of GM 1 or amphipathic poly(ethylene glycol) decreases 
the rate of liposome clearance. To understand the underlying mechanism by which liposome clearance is regulated by the RES, we have 
developed a simple liver perfusion system. Using m~use liver as a model, we demonstrated that hepatic uptake of neutral or negatively 
charged liposomes does not involve serum components. Liver uptake of liposomes is directly related to the surface characteristics of
liposomes. Liposomes with a neutral composition of phosphatidylcholine and cholesterol exhibit relatively low liver uptake. Inclusion of 
PS or DCP into these liposomes dramatically enhances liposome uptake by the perfused liver. Conversely, inclusion of GM~ or PEG 
derivatives into liposomes greatly reduces the liposome uptake by the mouse liver. In contrast o the neutral or negatively charged 
liposomes, serum enhances the liver uptake of positively charged liposomes. Such serum effect on liver uptake of the positively charged 
liposomes is likely due to liposome aggregations caused by serum proteins. Inhibition of the liver uptake for PS-containing liposomes 
using liposomes with different compositions suggests that liver uptake of liposomes may involve different receptors. 
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1. Introduction 
Much progress has been made in the last few years in 
the development of liposomes that have decreased affinity 
to the macrophages of the reticuloendothelial system (RES) 
and increased blood circulation half-life [1-4]. Such devel- 
opments appear to have brought liposome research into a 
new era. Many reports have appeared in the literature 
demonstrating the increased therapeutic efficacy by using 
such long-circulating liposomes over those with conven- 
tional compositions [5-9]. While it is certain that more and 
more applications of such long circulating liposomes will 
be developed, the mechanisms by which these liposomes 
avoid the RES uptake are still unknown. A more general 
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question still facing researchers i  how the macrophages of 
the RES, primarily the Kupffer cells in the liver, differenti- 
ate between liposomes that have only subtle differences in 
their structure, including surface charge, size and lipid 
composition [3,10,24]. 
Analyzing the results of previous experiments hat have 
used isolated cells as model system, two lines of evidence 
concerning this question have been accumulated. The hy- 
pothesis derived from the first line of evidence is called 
the opsonin dependent liposome clearance (for review, see 
[10]). It is hypothesized that liposomes, upon exposure to 
blood, become coated with plasma proteins. This process 
is thought to determine their recognition by the RES. 
Liposomes with different surface characteristics attract dif- 
ferent arrays of plasma proteins. The interaction of these 
proteins with liposomes may also vary both in quantity and 
quality, depending on liposome surface structure. These 
differences may account for the different patterns in their 
blood clearance and tissue distribution [10,11]. Using pri- 
mary culture of peritoneal macrophages a a model, early 
experiments have indicated that complement components 
[ 12], immunoglobulins [13] and fibronectin [14] may serve 
as opsonins to enhance liposome uptake. However, the 
6 F. Liu. D. Liu/Biochimica et Biophysica Acta 1278 (1996) 5-11 
activity of these components in the presence of other 
serum components have not been tested. It is not clear 
whether these components will have the same activity in 
the presence of high concentration f other serum proteins. 
On the contrary, substantial evidence has also been 
accumulated in support of an opsonin independent mecha- 
nism [15,16]. This hypothesis emphasizes the importance 
of liposome-cell interaction. It is postulated that the clear- 
ance rate of liposomes from blood by the RES is deter- 
mined by the surface characteristics of liposomes. Such 
characteristics an be directly recognized by receptors on 
macrophages of the RES and determine their affinity for 
the liposomes. Liposomes with higher affinity to these 
receptors are removed from the blood faster than those 
with low affinity. The recognition and uptake of liposomes 
by the RES does not involve the serum components [15,16]. 
Even though the results from such in vitro experiments 
correlated well with some of those from the in vivo 
experiments, one can not rule out the possibility that serum 
factors are involved in this process. This is because these 
results were obtained mainly in the absence or presence of 
fetal bovine serum specifically designed for cell culture 
and thus, may not contain all of the functional components 
that are involved in regulating liposome uptake by the 
macrophages. 
Even though some of the in vivo results have been 
reproduced in these in vitro model systems, the major 
problem is that these results from these model systems 
were obtained under special conditions that may not repre- 
sent the real situation in vivo. The reasons that these 
systems have not been able to provide conclusive vidence 
with regard to the mechanisms of liposome uptake by the 
RES are many. First of all, macrophages used in those 
experiments may have lost or changed their key properties 
with regard to their interaction with liposomes. Secondly, 
the assay conditions for liposome uptake in vitro is very 
different from an in vivo situation. Liposomes in blood 
with high flow rate in the body may interact with 
macrophages of the RES differently from those in culture 
where the interactions between liposomes and macrophages 
are more static. Lastly, the anatomic structure of the 
macrophages in RES has been lost in cell culture. Kupffer 
cells directly isolated from perfused liver using collage- 
nase have suffered the same problems [17]. 
In order to overcome these problems, we have explored 
the possibility of using a liver perfusion system to study 
such an important question. Liver perfusion is a special 
technique commonly used for studies of liver functions 
[18-21]. Compared to the isolated macrophages, liver 
perfusion better epresents he physiological conditions of 
the liver because damage to the liver macrophages can be 
minimized and the anatomic structure and blood flow 
dynamic of the liver can be preserved under the experi- 
mental conditions. 
In this report, we have systematically studied the effect 
of liposome composition on and the function of serum 
components in RES uptake of liposomes using a mouse 
liver perfusion system. A strong correlation between lipo- 
some uptake by the liver in in vivo and in vitro perfusion 
systems has been observed. Our results suggest hat the 
clearance of neutral or negatively charged liposomes by 
the RES in mice is an opsonin independent process and 
does not involve serum components. 
2. Materials and methods 
2.1. Materials 
Phosphatidylcholine (PC) from egg yolk and phospha- 
tidylserine (PS) from bovine brain were purchased from 
Avanti Polar Lipids (Birmingham, AL). Cholesterol (Chol) 
and dicetyl phosphate (DCP) were from Sigma (St. Louis, 
MO). Monosialoganglioside (GM 1) from bovine brain was 
purchased from Matreya (Pleasant Gap, PA). Diethylene- 
triaminepentaacetic acid stearylamide (DTPA-SA) [22], 
3/3-( N-(N',N'-dimethylaminoethane)carbamoyl)cholesterol 
(DC-Chol) [23] and dioleoyl N-(monomethoxy poly(ethyl- 
ene glycol) (Mr=2000)  succinyl)phosphatidylethanol- 
amine (PEG-PE) [4] were kindly provided by Dr. Leaf 
Huang (Department of Pharmacology, University of Pitts- 
burgh). 1~1InC13 (carrier-free) was from New England 
Nuclear (Wilmington, DE). Mice (NIH Swiss, male, 20-25 
g) were purchased from Harlan Sprague Dawley (Indianap- 
olis, IN). 
2.2. Preparation of liposomes 
Large multilamellar liposomes were prepared at room 
temperature by the method of extrusion [4]. Briefly, lipids 
dissolved in C13CH (for PC, PS, Chol and DC-Chol) or 
C13CH/methanol (1:1) (for GM 1 and PEG-PE) were mixed 
at a desired molar ratio and dried under a stream of N 2 
gas. The dried lipid films were then vacuum desiccated for 
at least 1 h to remove the residual organic solvent. A trace 
amount of 1~ ~ In-DTPA-SA (< 2 mol% of the total lipids) 
was included as lipid marker. The lipid films after vacuum 
desiccation were hydrated in PBS (pH 7.4) at a lipid 
concentration f 10 mM overnight and the lipid suspension 
was vortexed and extruded 15 times through two layers of 
Nucleopore membrane filter with a pore size of 0.8 /xm 
using LiposoFast extruding device (Avestin, Ottawa, 
Canada). The average diameter of the resulting liposomes 
was about 350-450 nm as measured by dynamic light 
scattering using a Coulter N4SD particle size analyzer 
(Coulter Electronic, Hiateah, FL). 
2.3. Single pass mouse liver perfusion 
Liposomes (0.12 /xmol total lipids in 12 ~1) were 
mixed with 200 /zl of either mouse serum (freshly col- 
lected) or buffer (Krebs-Henseleit buffer, pH 7.4) and 
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incubated for 10 min at 37°C. The mixture was then 
diluted to 2.4 ml with buffer and 2 ml of the diluted 
mixture was perfused via the portal vein through the 
mouse liver which was prewashed with 3 ml of buffer 
(prewarmed to 37°C). Mice were anesthetized by 2,2,2-tri- 
bromoethanol (0.6 ml, 20 mg/ml,  i.p.) during the experi- 
ment. The inferior vena cava was cut at the beginning of 
the experiments o drain the blood, immediately followed 
by washing and subsequent perfusion with liposomes. 
Liposomes were only allowed to pass through the liver 
once. Unbound liposomes in the liver were removed by 
washing the perfused liver with 5 ml of buffer via the 
same route. The perfusion rate was kept constant at 2 
ml/min. The amount of liposomes taken up by the liver 
was analyzed by measuring the ~l~In radioactivity in the 
liver and presented as percentage of total amount of lipo- 
somes perfused. 
2.4. Turbidin, measurements 
Same amount of liposomes (0.12 /xmol total lipids in 
12 /xl) as used for the perfusion studies was incubated 
with 200 /,l of either PBS or mouse serum for 10 min at 
37°C. The incubation mixture was then diluted with PBS 
to a final volume of 0.6 ml. The turbidity of the diluted 
liposome solution was immediately measured in a spectro- 
photometer at a wavelength of 600 nm. 
2.5. Infusion qf liposomes in live animals 
Liposomes (0.1 /.tmol total lipids in 100 /.tl) were 
infused into the anesthetized mice via the portal vein in 1 
rain. At the end of the infusion, the inferior vena cava was 
cut to drain the blood followed by perfusing the liver with 
5 ml of prewarmed buffer to remove any unbound lipo- 
somes in the liver. The total liver uptake of liposomes was 
then analyzed by measuring the amount of ~1 ~ In radioactiv- 
ity in the liver using a gamma-counter. 
2.6. Inhibition of liver uptake of PS-containing liposomes 
by liposomes with different composition 
The inhibition experiments were performed in two ways. 
Firstly, different amounts of liposomes containing 
PC/Chol, PC/Cho l /DCP or PC/Chol /PS were mixed 
with PS-containing liposomes (Ill In-labeled) and the mix- 
ture was then perfused through the liver under the condi- 
tions described above. Secondly, liposomes (2 /xmol total 
lipids) with different compositions were first perfused 
through the liver, the perfused liver was washed with 3 ml 
of buffer and the testing liposomes (ll lin_labeled PS-con- 
raining liposomes, 0.1 /xmol total lipids) were then per- 
fused through the same liver. The liver uptake of PS-con- 
taining liposomes (testing liposomes) was then analyzed 
accordingly. 
3. Results 
3.1, Composition dependent Iiposome uptake by liver 
Liposome composition has been known to be the most 
important factor determining the rate of liposome clear- 
ance by the RES and therefore the blood circulation time 
in vivo [1-4]. For example, inclusion of PS, PA, DCP or 
positively charged lipids into the liposome bilayer in- 
creases liposome clearance by the RES [24] while inclu- 
sion of GM~ or amphipathic PEG derivatives decreases the 
rate of liposome clearance by the RES [1-4]. The question 
that needs to be answered, however, is how liposomes are 
recognized by the RES. The main dispute concerning the 
mechanism of liposome recognition between opsonin-de- 
pendent and opsonin-independent hypotheses is whether 
serum components play an important role in liposome 
recognition. To test the serum effect, we have chosen a 
few representative liposome compositions for our experi- 
ments. These compositions have been demonstrated to 
have very different effects in regulating the blood halt-lives 
of liposomes [2-4,24]. As shown in Fig. I. about 9% of 
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Fig. 1. Composition dependent liposome uptake by mouse liver. Lipo- 
somes (0.1 p~mol total lipids) were either perfllsed (A) or infused (B) 
through the mouse liver according to the methods described in Section 2. 
1, PC/Chol (10:5): 2. PC/Cho l /DCP (10:5:1): 3, PC/Chol /PS(  10:5:1); 
4, PC/Chol/DC-Chol (10:5:1): 5, PC /Cho l /GM l (10:5:1) and 6. 
PC/Chol/PEG2000-PE (10:5:1). (open bar) in buffer: (hatched bar) in 
serum 01 = 3). 
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the total perfused liposomes with a basic composition of 
PC/Chol (10:5, molar ratio) were taken up by the liver 
after a single pass perfusion. Inclusion of 6.25% (mol) PS 
or DCP into such liposomes increased the total liver 
uptake to 23 and 30% respectively. By contrast, liposomes 
containing equal mol% of GMI or PEG-PE 
(PC/Chol /GM 1 or PEG2000-PE = 10:5:1) decreased the 
total liposome uptake by the liver to less than 3% (Fig. 
1A). Under such conditions, preincubation of liposomes 
with freshly collected mouse serum (200/zl) did not affect 
the total liposome uptake. Using plasma (200 /xl), blood 
(400 /zl) or larger amount of serum (400 /zl) did not 
change the total liposome uptake by the liver (data not 
shown). Interestingly, the only case where serum played a 
significant role in affecting the total liver uptake of lipo- 
some under such conditions was when liposomes con- 
tained 6.25% DC-Chol. The liver uptake of liposomes 
containing DC-Chol was enhanced about 3-fold in the 
presence of serum. 
To demonstrate hat the high liver uptake of liposomes 
in the absence of serum is truly serum independent and not 
due to the residual amount of unwashed blood components 
in the liver, we have varied the volume of washing buffer 
and looked whether the total liposome uptake by the 
perfused liver is affected by the volume of washing buffer 
used. The logic of this approach is straight forward, if the 
liver uptake of liposomes in the absence of serum is due to 
the small amount of unwashed blood components left in 
the liver, increase of the amount of washing buffer should 
decrease the amount of blood contaminant in the liver and, 
therefore, reduce the total liver uptake of liposomes. Using 
PS containing liposomes as an example, it was found that 
the liver uptake of PS liposomes by the perfused livers 
remained constant between 20-25% regardless of the vol- 
ume (ranging from 3 to 10 ml per mouse liver) being used 
for washing prior to the administration of liposomes, sug- 
gesting that the liver uptake of those liposomes is truly 
through direct recognition. 
To confirm whether the pattern of liposome uptake by 
the liver in our perfusion system correlates well with those 
in vivo, we infused the same amount of liposomes via the 
portal vein into live animals under anesthesia over a period 
of 1 min (the same period used for perfusion). After 
infusion, an incision was made at the inferior vena cava to 
drain the blood and subsequently the liver was washed 
with 5 ml of buffer via portal vein to remove unbound 
liposomes in the liver. It is obvious from Fig. 1B that the 
pattern of liver uptake of liposomes under such conditions 
is similar to that from the perfusion experiments. Lipo- 
somes containing PS, DCP or DC-Chol, which exhibit 
high liver uptake in perfusion, showed much higher accu- 
mulation in the infused liver. Liposomes of PC/Chol 
showed a moderate liver uptake. Liposomes containing 
GM1 or PEG2000-PE showed minimal iver accumulation. 
There was a 2-3-fold increase in total liposome uptake by 
the infused liver over that by perfused liver for liposomes 
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Fig. 2. PS concentration dependent liposome uptake by the perfused liver. 
Liposomes with various concentrations of PS were prepared using PC and 
Chol as matrix lipids (PC/Chol = 10:5, molar ratio). The concentrations 
of PS in liposomes are presented as mole percentage of the total lipids. 
The liver perfusions were performed in the absence of serum (n = 3). 
composed of PC/Chol, PC/Chol/PS,  PC/Chol /DCP 
and PC/Chol/DC-Chol. 
3.2. Effect of PS concentrations in liposomes on liver 
uptake 
The results shown in Fig. 1 strongly suggest hat liver 
uptake of liposomes with a neutral or negatively charged 
surface is through direct recognition. Liposomes with a 
simple composition of PC/Chol showed a moderate 
amount of liver uptake (9%), suggesting a relatively low 
affinity for such liposomes by the Kupffer cells. Inclusion 
of PS or DCP into liposomes dramatically enhances the 
total liposome uptake by the perfused liver (23% and 30%, 
respectively), indicating that both PS and DCP in the 
liposomes erve as positive signal for liposome recognition 
by the Kupffer cells. If this is true, one would predict hat 
the total liposome uptake by the liver should depend on the 
concentration of these components in liposomes. To test 
this hypothesis, we have prepared a series of liposomes by 
varying the concentration of PS in the bilayer and tested 
their liver uptake using our liver perfusion system. The 
results are summarized in Fig. 2. Liver uptake is very 
sensitive to the PS concentration i  the liposomes. It 
required as little as 3% of PS in liposomes for the liver to 
reach maximum uptake. Further increases (up to 12%) of 
PS in liposomes did not result in any additional liposome 
uptake. Again, serum did not exhibit any effect on liver 
uptake of liposomes containing higher concentration f PS 
(data not shown). 
3.3. Effect of DC-Chol concentration i liposomes on the 
liver uptake of liposomes 
It is evident from Fig. 1 that serum enhances the liver 
uptake of liposomes containing DC-Chol. DC-Chol is a 
derivative of cholesterol that is commonly used as a 
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Table 1 
Effect of the concentration of DC-Chol 
uptake ~ 
in liposomes on total liver 
Liposomes DC-Chol Liver uptake (%) 
PC/Chol/DC-Chol  concentration buffer serum 
(molar ratio) (%) 
10:5:1 6.3 7.7_+2.3 20.3_+0.4 
10:4:2 12.5 64.2+ 1.4 88.1 _+3.2 
10:3:3 18.8 82.3_+7.2 ND b 
10:0:5 33.3 89.0--+0.4 90.4-+2.8 
~' Liposomes (0.12 p, mol total lipids) with different concentration of 
DC-Chol in liposomes were incubated with either 200 /zl of buffer or 
freshly collected mouse serum for 10 rain at 37°C. The mixture was then 
diluted to 2.4 ml with prewarmed buffer and 2 ml of the diluted 
liposomes was peffused through the prewashed mouse liver. Data repre- 
sents the average (S.D.) (n _> 3) 
b Not determined. 
vehicle for gene delivery [23]. Theoretically, a high liver 
uptake of such positively charged liposomes should be 
expected considering the fact that the cell surface is nega- 
tively charged. The reason that only about 8% of lipo- 
somes (PC/Chol/DC-ChoI= 10:5:1) were taken up by 
the perfused liver in the absence of serum is likely due to 
the insufficient concentration of DC-Chol in liposomes. 
Liposomes with 6.25% of DC-Chol may not show strong 
positive on their surface such that no strong electrostatic 
interaction between liposomes and liver cells will occur. 
To test this hypothesis, liposomes with increasing concen- 
trations of DC-Chol were prepared and tested for their 
liver uptake in our perfusion system. As shown in Table 1, 
increase in DC-Chol concentration i  liposomes resulted in 
an elevated total liposome uptake in the absence of serum. 
Liposomes containing 18% or greater of DC-Chol in- 
creased the total liver uptake of liposomes to over 80%. 
With 12.5% of DC-Chol, however, over 60% of the lipo- 
somes were taken up by the perfused liver. Again, serum 
enhances the liver uptake of these liposomes (Table 1). 
3.4. Serum induced aggregation of liposomes containing 
DC-Chol 
Given the fact that serum proteins are negatively charged 
under physiological conditions, we reasoned that the serum 
effect on the liver uptake of the positively charged lipo- 
somes may be due to the liposome aggregation i duced by 
negatively charged serum proteins. To test such possibility, 
we measured the turbidity changes upon the incubation of 
liposomes with serum. As shown in Table 2, an increase in 
OD600 was observed after serum treatment for liposomes 
containing DC-Chol. The degree of turbidity increase de- 
pends on the DC-Chol concentration. Liposomes with 
12.5% DC-Chol gave an OD600 of 0.122 compared to 
0.097 when the concentration f DC-Chol was 6.3%. As a 
control, PS-containing liposomes showed no increase in 
turbidity. The OD600 for PS liposomes approximated to the 
Table 2 
Serum induced turbidity change of liposomes 
Liposomes(molar ratio) Size (S.D.) (nm) Treatments OD600 ~ 
PC/Chol/DC-Chol (10:5:1) 432 (broad) PBS 0.030 
serum 0.097 
PC/Chol/DC-Chol (10:4:2) 392 (broad) PBS 0.021 
serum 0.121 
PC/Chol /PS (10:5:1) 355 (broad) PBS 0.019 
serum 0.072 
Liposomes (0.12 /xmol total lipid in 12 /xl) were incubated with 200 /zl 
of either PBS (pH 7.4) or mouse serum for 10 rain at 37°C and then 
diluted to a final volume of 0.6 ml with PBS. The turbidity of the samples 
was measured in a spectrophotometer at OD(,o0. The OD(~0o for PBS 
containing the same amount of serum without liposomes was 0.054. 
aData represent an average of duplicate xperiments. 
sum of OD600 for liposomes (0.019) in PBS and diluted 
serum (0.054). 
3.5. LiL, er uptake of" PS-containing liposomes is mediated 
by specific receptors 
It is evident from Fig. 1 that both PS and DCP-contain- 
ing liposomes howed high liver uptake regardless of the 
presence of serum. One question we asked was whether 
such high liver uptake for both types of liposomes was 
mediated through the same receptors. To answer this ques- 
tion, a series of competition experiments was performed. 
In these experiments, ~In-labeled PS-containing lipo- 
somes (testing liposomes) were mixed with increasing 
amounts of unlabeled liposomes of different compositions 
and then co-perfused through the liver. As shown in Fig. 3, 
the total liver uptake of testing liposomes was only sensi- 
tive to liposomes of the same composition (PC/Chol/PS 
= 10:5:1). The total liposome uptake of testing liposomes 
reduced from 20% in the absence of competing liposomes 
to about 5% when 2 /zmol of liposomes of the same 
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Fig. 3. Inhibition of the liver uptake of liposomes containing PS. I i iln_ 
labeled PS-containing liposomes (0.1 /xmol) were mixed with different 
amounts of liposomes composed of PC/Chol (10:5) ( [] ), PC/Chol /DCP 
(10:5:l) (O) or PC/Chol/PS (10:5:l) (O) and the mixture was then 
perfused through the liver in the absence of serum (n = 3). 
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Table 3 
Effect of pre-perfusion f liver by different liposomes on liver uptake of 
liposomes containing PS 
Liposomes pre-perfused (molar ratio) Liver uptake (%) 
None 22.3 _+ 1.2 
PC/Chol (10:5) 21.2 - 0.4 
PC/Chol/DCP (10:5:1) 20.1 + 1.6 
PC/Chol/PS (10:5:1) 6.3 +0.5 
The mouse liver was pre-perfused with either buffer or liposomes (2
/zmol total ipids without radio label) of different compositions. The 
pre-perfused liver was then washed with 3 ml buffer and then perfused 
again with I11 In-labeled PS-containing liposomes (0.1 /xmol total lipids). 
The methods ofperfusion and the data nalysis are the same as those in 
Table 1. Data represent average (S.D.) of three xperiments. 
composition were co-perfused. Interestingly, co-perfusion 
of the testing liposomes with liposomes either containing 
DCP or simply PC/Chol did not change the total level of 
liver uptake of the PS-containing liposomes (testing lipo- 
somes). For instance, 20-fold excess of liposomes with or 
without DCP over the testing liposomes did not affect the 
total liver uptake of the testing liposomes. Pre-perfusion of 
the liver with high dose of either PC/Chol or 
PC/Chol /DCP liposomes (2 /xmol total lipids) did not 
decrease the total liver uptake of PS-containing liposomes 
either (Table 3), suggesting that the liver uptake of PS 
liposomes is through a specific mechanism that is different 
from those for DCP-containing or PC/Chol liposomes. 
4. Discussion 
We have clearly demonstrated in this report that the 
hepatic uptake of liposomes in mice does not seem to 
involve serum components (Fig. 1A). Liposomes with a 
basic composition of egg PC and cholesterol exhibit a 
basal level liver uptake, which can be modulated by the 
inclusion of additional membrane components. Inclusion 
of PS or DCP into the liposomes enhances the liposome 
uptake while inclusion of GM~ or PEG2000-PE into lipo- 
somes reduces the total liposome uptake by the liver. The 
activity of the included lipids in modulating the liver 
uptake of liposomes depends on their concentration i  the 
liposome bilayer (Fig. 2). The removal of PS-containing 
liposomes by the liver is likely mediated through mem- 
brane receptors that are different from those for DCP-con- 
taining liposomes (Fig. 3). 
One exception to the above conclusion among the lipo- 
somes tested so far is liposomes containing positively 
charged lipids (PC/Chol/DC-Chol, Fig. 1 and Table 1). 
For positively charged liposomes, serum increases liver 
uptake. Such serum promoted liver uptake of liposomes, 
while seeming to support he notion that serum compo- 
nents play an important role in determining the affinity of 
the RES for the liposomes, is most likely through a 
nonspecific nature. It is likely that negatively charged 
serum proteins cause aggregation between positively 
charged liposomes (Table 2). The aggregated liposomes 
were then trapped in the liver while attempting to pass 
through the liver. An alternative explanation for the serum 
effect on these positively charged liposomes is that lipo- 
somes may be coated with serum proteins through electro- 
static interaction between liposomes and serum proteins. 
The protein-coated liposomes were then taken up by the 
liver cells. The level of liver uptake of liposomes could be 
related to the amount of serum proteins bound per lipo- 
some which will be determined by serum to liposome ratio 
and charge density on liposome surface. 
Comparing the total liver uptake of liposomes by the 
method of perfusion to that by infusion in live animals, the 
liver uptake of liposomes composed of PC/Chol, 
PC/Chol/DCP, PC/Cbol /PS and PC/Chol/DC-Chol 
was 2- to 3-fold higher than those in perfusion (Fig. 1). 
This is likely due to the fact that liposomes infused into 
the live animals have multiple passes through the liver, 
while under our perfusion conditions, liposomes were only 
allowed to pass the liver once. For infusion, liposomes that 
escaped from the first pass through the liver may re-enter 
the liver and be taken up by the liver in the following pass. 
Nevertheless, the direct correlation between the uptake of 
liposomes by perfusion and infusion proves the usefulness 
and reliability of our in vitro liver perfusion system for 
studying the mechanism of liposome clearance by the 
RES. 
While the evidence for direct recognition of liposomes 
by the liver cells is strong, the detail mechanism of such 
recognition is yet to be elucidated. For liposomes with no 
net charge (PC/Chol in our experiments) or with nega- 
tively charged surface such as liposomes containing PS or 
DCP, it has been well documented that Kupffer cells of the 
liver are directly involved [24]. In order for Kupffer cells 
to take up liposomes, liposomes have to bind to the surface 
of the Kupffer cells. The molecules that are responsible for 
such binding on the surface of the Kupffer cells should be 
able to differentiate the hydrophilic head groups of the 
liposomes. It has been postulated previously that scavenger 
receptors of the Kupffer cells are responsible for such 
recognition [27]. Obviously, our results in Fig. 3, although 
do not rule out the involvement of scavenger receptors, 
strongly suggest hat other receptors are likely involved. 
The fact that the liver uptake of PS-containing liposomes 
can not be blocked by the DCP-containing liposomes, 
which also exhibit a high liver uptake both in vitro and in 
vivo, would suggest hat these two types of liposomes are 
taken up by the Kupffer cells through different mecha- 
nisms. It will be interesting to know whether the uptake of 
other types of liposomes, including those containing PA 
and PG which show high rate of blood clearance, also 
involve different receptors. 
In view of the liver uptake of positively charged lipo- 
somes in the absence of serum, we believe that the high 
level of liposome uptake by the liver is most likely due to 
the electrostatic interactions between positively charged 
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liposomes and negatively charged cell surfaces. Cells lin- 
ing the blood vessels in the liver may be all involved. The 
involvement of hepatocytes i  less likely concerning the 
diameter of the fenestration. The diameter (350-450 nm) 
of the liposomes used in our experiments i much larger 
than the pore size of the fenestration (about 100 nm in 
average [25]). The linear increase in liver uptake of lipo- 
somes with an increase in DC-Chol concentration i  lipo- 
somes supports the notion of nonspecific binding. 
One obvious question raised by our results is how to 
incorporate the results of previous experiments in the 
literature into the common scheme of the mechanism of 
liposome uptake by the RES. In fact, using rat liver 
perfusion systems, a few groups [19,20] including ours [21] 
have reported that serum opsonins are essential for liver 
uptake of liposomes. For example, Kiwada et al. [19,20] 
reported that liver uptake of liposomes containing DCP is 
solely dependent on the serum. We have also recently 
reported that uptake of PS-containing liposomes is also 
dependent on serum [21]. The obvious difference between 
those experiments and the experiments described in this 
report is the difference in the animal model. It is likely that 
different animal species use different mechanism in regu- 
lating the clearance of liposomes. In fact, such animal 
species dependent mechanism for liposome clearance has 
been previously reported [26]. We have recently found that 
liposomes containing GM~ show an opposite effect in 
regulating liposome circulation time in mice and rats. In 
mice, it decreases the affinity of the RES for liposomes 
and prolongs the blood circulation half-life. While in rats it 
increases the affinity of the RES for the liposomes and, 
therefore, decreases their blood circulation half-life [26]. 
Such animal species dependent liposome uptake by the 
liver is also found in liposomes with other compositions 
(Liu, D. et al. [28]). 
In summary, we have shown in an in vitro liver perfu- 
sion system that hepatic uptake of liposomes takes place 
through the direct recognition of the surface characteristics 
of liposomes by the Kupffer cells. No specific serum 
components are involved in such a recognition process for 
the liposomes tested so far. It appears that the rate of 
liposome clearance from the blood by the RES in mice, 
mainly the liver Kupffer cells, depends on the affinity of 
the Kupffer cells for the liposomes. Such affinity is deter- 
mined by the liposome composition. Inclusion of PS or 
DCP into liposomes composed of PC/Chol increases the 
affinity and therefore nhances the liver uptake and re- 
duces the blood circulation time. In contrast, inclusion of 
GM~ or PEG-PE into liposomes of the same composition 
decreases the affinity, resulting in a prolonged liposome 
circulation time in blood. The function of GM~ and PEG- 
PE in this case, however, is not to prevent he binding of 
the serum opsonins to liposome surface, instead, it is to 
sterically hinder the binding of liposomes to the receptor 
of Kupffer cells for PC/Chol liposomes. Characterization 
of the receptors that are responsible for the binding of 
Biophysica Acta 1278 (1996) 5-11 11 
liposomes and their relation to the binding of different 
liposomes are currently under investigation. 
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